Moderna Will Start To Outrun Coronavirus Competition In 2021, Analyst Says
September 25, 2020 at 16:30 PM EDT
Oppenheimer analyst Hartaj Singh maintained an Outperform rating and a $108 price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|